US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quoin Pharmaceuticals

8.38

-0.0900-1.06%

Post-market: 8.380.00000.00%19:20 EDT

Volume:9.47K

Turnover:78.68K

Market Cap:4.93M

PE:-0.21

High:8.58

Open:8.14

Low:8.09

Close:8.47

Loading ...

Overview Company News Filings

Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

QNRX: With Clinical Activities Expanding, QNRX Expects Cash Runway Into 2Q26

Zacks Small Cap Research

Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings Summary

Quoin Pharmaceuticals FY 2024 GAAP EPS $(1.91) Beats $(2.10) Estimate, Quoin Had Approximately $14.1M In Cash, Cash Equivalents And Marketable That Is Expected To Fund The Company's Operations Into Q2 Of 2026

Quoin Pharmaceuticals reports Q4 EPS (35c) vs ($2.08) last year

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

Quoin Pharmaceuticals Ltd expected to post a loss of 46 cents a share - Earnings Preview

Quoin Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on Thursday, March 13, 2025

QNRX: More Positive Data Supporting Efficacy of QRX003 for NS; Campaign to Raise Awareness of the Disease

Zacks Small Cap Research

Calendar of U.S. Earnings Expected in the Week Ahead

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study

Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome

Quoin Pharmaceuticals launches ‘NETHERTON NOW’ campaign

Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure

Insider Buyers At Quoin Pharmaceuticals Likely Disappointed With 13% Slide

Simply Wall St.

Quoin Pharmaceuticals: Buy Rating Affirmed Amidst Potential First-Mover Advantage in Netherton Syndrome Treatment

Skinvisible Advances with Quoin Pharmaceuticals’ FDA Clearance

Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome

Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies

ACCESS Newswire

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/QNRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QNRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","market":"US","secType":"STK","nameCN":"Quoin Pharmaceuticals","latestPrice":8.38,"timestamp":1749844800000,"preClose":8.47,"halted":0,"volume":9472,"hourTrading":{"tag":"盘后","latestPrice":8.38,"preClose":8.38,"latestTime":"19:20 EDT","volume":53,"amount":434.6,"timestamp":1749856843831},"delay":0,"floatShares":515649,"shares":588166,"eps":-39.34639,"marketStatus":"Market Closed","change":-0.09,"latestTime":"06-13 16:00:00 EDT","open":8.14,"high":8.5799,"low":8.0851,"amount":78675.5008,"amplitude":0.058418,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-39.34639,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"adrRate":35,"exchange":"NASDAQ","adjPreClose":8.47,"postHourTrading":{"tag":"盘后","latestPrice":8.38,"preClose":8.38,"latestTime":"19:20 EDT","volume":53,"amount":434.6,"timestamp":1749856843831},"volumeRatio":0.81744},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","floatShares":515649,"roa":"-47.40%","roe":"-138.82%","lyrEps":-66.902093,"volumeRatio":0.81744,"shares":588166,"dividePrice":0,"high":8.5799,"amplitude":0.058418,"preClose":8.47,"low":8.0851,"week52Low":5.01,"pbRate":"0.83","week52High":54.95,"institutionHeld":0,"latestPrice":8.38,"eps":-39.34639,"divideRate":0,"volume":9472,"delay":0,"ttmEps":-39.34639,"open":8.14,"prevYearClose":22.7745,"prevWeekClose":8.82,"prevMonthClose":8.53,"prevQuarterClose":7.8365,"fiveDayClose":8.82,"twentyDayClose":7.7,"sixtyDayClose":10.4825},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QNRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522024641","title":"Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2522024641","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522024641?lang=en_us&edition=fundamental","pubTime":"2025-03-25 19:51","pubTimestamp":1742903505,"startTime":"0","endTime":"0","summary":"March 25 (Reuters) - Quoin Pharmaceuticals Ltd <2EBy.BE>::*QUOIN PHARMACEUTICALS FILES U.S. PATENT APPLICATION FOR NOVEL TOPICAL FORMULATIONS TO TREAT NETHERTON SYNDROME AND OTHER SKIN DISEASES*QUOIN ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nRSD3Jxzq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["74907L409","QNRX","BK4139"],"gpt_icon":0},{"id":"2520347501","title":"QNRX: With Clinical Activities Expanding, QNRX Expects Cash Runway Into 2Q26","url":"https://stock-news.laohu8.com/highlight/detail?id=2520347501","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520347501?lang=en_us&edition=fundamental","pubTime":"2025-03-17 22:10","pubTimestamp":1742220600,"startTime":"0","endTime":"0","summary":"Progressing studies of QRX003; positive interim clinical data. Quoin Pharmaceuticals , a clinical stage, specialty pharmaceutical company that focuses on developing treatments for rare and orphan diseases, is expanding clinical activities studying lead asset QRX003 for the treatment of Netherton Syndrome . Quoin has active NS studies that are being conducted concurrently under an open Investigational New Drug  application with the FDA. The company believes it is the only development company developing treatment for NS that is conducting dual studies concurrently under an open IND application.The concurrent open-label study clinical studies has yielded positive interim results. Quoin believes the data generated to-date from its ongoing open-label and other studies has shown evidence that QRX003 can contribute to improvement across all measured clinical endpoints. The company expects its clinical activities will produce a solid database that will be key to its regulatory approval submiss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qnrx-clinical-activities-expanding-qnrx-141000728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2519983408","title":"Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2519983408","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519983408?lang=en_us&edition=fundamental","pubTime":"2025-03-13 21:31","pubTimestamp":1741872681,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd reports results for the quarter ended December 31 - Earnings SummaryQuoin Pharmaceuticals Ltd QNRX.OQ reported a quarterly adjusted loss of 35 cents per share for the quarter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nL8N3PW17J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"gpt_icon":0},{"id":"2519783841","title":"Quoin Pharmaceuticals FY 2024 GAAP EPS $(1.91) Beats $(2.10) Estimate, Quoin Had Approximately $14.1M In Cash, Cash Equivalents And Marketable That Is Expected To Fund The Company's Operations Into Q2 Of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2519783841","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519783841?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:37","pubTimestamp":1741865820,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.91) per share which beat the analyst consensus estimate of $(2.10) by 9.05 percent.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44299174/quoin-pharmaceuticals-fy-2024-gaap-eps-1-91-beats-2-10-estimate-quoin-had-approximately-14-1m-in-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Quoin Pharmaceuticals FY 2024 GAAP EPS $(1.91) Beats $(2.10) Estimate, Quoin Had Approximately $14.1M In Cash, Cash Equivalents And Marketable That Is Expected To Fund The Company's Operations Into Q2 Of 2026","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"gpt_icon":0},{"id":"2519336448","title":"Quoin Pharmaceuticals reports Q4 EPS (35c) vs ($2.08) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2519336448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519336448?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:36","pubTimestamp":1741865811,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced recent corporate accomplishments and provided an update on its fourth quarter and full-year 2024 progress. Q...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-reports-q4-eps-35c-vs-2-08-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-reports-q4-eps-35c-vs-2-08-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX"],"gpt_icon":0},{"id":"2519838454","title":"Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2519838454","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519838454?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:30","pubTimestamp":1741865400,"startTime":"0","endTime":"0","summary":"ASHBURN, Va., March  13, 2025  (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \"Company\" or \"Quoin\"), a late clinical-stage specialty pharmaceutical company focused on rare and orph","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042092/0/en/Quoin-Pharmaceuticals-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2517863714","title":"Quoin Pharmaceuticals Ltd  expected to post a loss of 46 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517863714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517863714?lang=en_us&edition=fundamental","pubTime":"2025-03-07 19:29","pubTimestamp":1741346945,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd  expected to post a loss of46cents a share - Earnings Preview Quoin Pharmaceuticals Ltd QNRX.OQ, QNRX.O is expected to show no change in quarterly revenue when it reports  re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ0RI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX"],"gpt_icon":0},{"id":"2517547471","title":"Quoin Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on Thursday, March 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2517547471","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517547471?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:00","pubTimestamp":1741266000,"startTime":"0","endTime":"0","summary":"ASHBURN, Va., March  06, 2025  (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the \"Company\" or \"Quoin\"), a late clinical-stage specialty pharmaceutical company focused on rare and orph","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/06/3038132/0/en/Quoin-Pharmaceuticals-to-Announce-Fourth-Quarter-and-Full-Year-2024-Financial-Results-on-Thursday-March-13-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2517192615","title":"QNRX: More Positive Data Supporting Efficacy of QRX003 for NS; Campaign to Raise Awareness of the Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192615","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517192615?lang=en_us&edition=fundamental","pubTime":"2025-03-05 23:16","pubTimestamp":1741187760,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals  is a clinical stage, specialty pharmaceutical company that focuses on developing treatments for rare and orphan diseases, initially in the dermatology space. The company is advancing clinical studies to evaluate lead asset QRX003 for the treatment of Netherton Syndrome . Quoin has active NS studies that are being conducted concurrently under an open Investigational New Drug  application with the FDA. The company believes it is the only development company developing treatment for NS that is conducting dual studies concurrently under an open IND application. Two U.S. trials utilize the same investigators and clinical sites, which Quoin expects will result in substantial operational synergies and cost savings. QNRX is also assessing QRX003 in an NS pediatric patient in an Investigator Pediatric NS study, with plans to enroll additional pediatric patients at other sites.QNRX is advancing clinical studies to evaluate lead asset QRX003 for treatment of Netherton Syndr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qnrx-more-positive-data-supporting-151600821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2517990373","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2517990373","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517990373?lang=en_us&edition=fundamental","pubTime":"2025-03-05 19:00","pubTimestamp":1741172400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Abercrombie & Fitch                              4Q      3.54   7:30 AM. ·ACRES Cmmcl Rlty                                 4Q       .36   4:15 PM. ·Descartes Sys Gp                                4Q       .43   5:00 PM. ·Dine Brands Global                               4Q      1.34   7:00 AM. ·Foot Locker Inc.                                  4Q       .72   6:45 AM. ·Forge Global Hldgs                              4Q      (.09)  4:10 PM. ·Global Ship Lease                                4Q      2.31   8:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GAP","OCGN","SGHT","BF.A","RSKD","CAPR","BF.B","HIPO","CRVS","FL","QNRX","DESP","GRND","PAM","CRMT","ECOR","SKLZ","ATXS","LPSN","TCRX","TREE","FDUS","KR","FRGE","MRX","ALNT","VEEV","LB","HDSN","AMTX","ARCT","EYPT","ZS","BALY","ALTG","SVCO","DOMO","ALGS","CNQ","FSM","AVGO","MRVL","ATER","ZYME","SNBR","ARQ","IMRX","AKA","DIN"],"gpt_icon":1},{"id":"2516673956","title":"Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2516673956","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516673956?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:30","pubTimestamp":1741091400,"startTime":"0","endTime":"0","summary":"Target Indications Include Microcystic Lymphatic Malformations, Venous Malformations and AngiofibromasProprietary Invisicare Delivery Technology Designed to Optimize Local Skin Penetration Company Pla","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036382/0/en/Quoin-Pharmaceuticals-Files-U-S-and-International-Patent-Applications-for-Novel-Topical-Rapamycin-Formulations-to-Treat-Rare-Disease-Indications.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","CVM","BK4139"],"gpt_icon":0},{"id":"2514809950","title":"Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2514809950","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514809950?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:30","pubTimestamp":1740659400,"startTime":"0","endTime":"0","summary":"Groundbreaking data from first whole body application of QRX003 underscores potential efficacyTransformational improvement in disease state after just 2 weeks of treatment Clear visual evidence of ski","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033744/0/en/Quoin-Pharmaceuticals-Announces-Highly-Positive-Whole-Body-Clinical-Data-from-Ongoing-Pediatric-Netherton-Syndrome-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139","IGA"],"gpt_icon":0},{"id":"2514509508","title":"Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2514509508","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514509508?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:30","pubTimestamp":1740486600,"startTime":"0","endTime":"0","summary":"Global Premiere Set for Rare Disease Day, Feb. 28, 2025ASHBURN, Va., Feb.  25, 2025  (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical stage spe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/25/3031904/0/en/Quoin-Pharmaceuticals-Launches-First-Episode-of-NETHERTON-NOW-Video-Series-to-Raise-Awareness-for-Netherton-Syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4566","LU2125909759.SGD","BK4608","ETH","QNRX","BK4550","LU0320765059.SGD","LU2125909247.SGD","LU1803068979.SGD","LU1923622291.USD","BK4503","NOW","LU0708995401.HKD","LU0820561909.HKD","LU1116320901.HKD","LU1153585028.USD","LU0011850046.USD","LU1923623000.USD","LU2286300806.USD","LU1974910355.USD","LU0672654240.SGD","LU1989772923.USD","BK4585","LU0109391861.USD","BK4534","LU2087625088.SGD","IE00BMPRXR70.SGD","LU0689472784.USD","LU0109392836.USD","LU0943347566.SGD","LU0316494557.USD","LU2023250843.SGD","BK4607","LU1923622614.USD","LU2063271972.USD","IE00B894F039.SGD","LU0265550946.USD","LU1989764748.USD","LU0820561818.USD","LU0353189680.USD","IE00B19Z9P08.USD","LU1323610961.USD","BK4588","LU0265550359.USD","LU1267930730.SGD","LU1989764664.SGD","LU2458330169.SGD","IE00BZ9MQY76.HKD","IE00B19Z9Z06.USD"],"gpt_icon":0},{"id":"2508455607","title":"Quoin Pharmaceuticals launches ‘NETHERTON NOW’ campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2508455607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508455607?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:37","pubTimestamp":1738672648,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) has launched the “NETHERTON NOW” campaign to shed light on the profound and poorly understood impacts of Netherton Syn...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-launches-netherton-now-campaign?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-launches-netherton-now-campaign?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989764748.USD","LU2125909593.SGD","LU0320765059.SGD","LU1989764664.SGD","IE00B19Z9Z06.USD","LU1116320737.USD","LU1551013425.SGD","IE00BZ9MQY76.HKD","LU0354030511.USD","LU0889565833.HKD","LU2433249047.HKD","IE00B894F039.SGD","LU1064131342.USD","LU0011850046.USD","BK4543","LU2125909916.SGD","LU0082616367.USD","LU0265550946.USD","BK4585","LU2023250843.SGD","LU1974910355.USD","LU1116320901.HKD","QNRX","BK4503","LU1989772840.SGD","BK4581","BK4588","LU1989772923.USD","LU0354030438.USD","LU0348723411.USD","LU1153585028.USD","BK4528","LU0820561818.USD","LU0689472784.USD","BK4566","LU2458330169.SGD","IE00BMPRXR70.SGD","LU1923622291.USD","LU0820561909.HKD","LU1923623000.USD","LU1267930730.SGD","IE00BMPRXN33.USD","LU2106854487.HKD","LU2286300806.USD","BK4601","LU2063271972.USD","ETH","LU1917777945.USD","LU0672654240.SGD"],"gpt_icon":0},{"id":"2508455512","title":"Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure","url":"https://stock-news.laohu8.com/highlight/detail?id=2508455512","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508455512?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:30","pubTimestamp":1738672200,"startTime":"0","endTime":"0","summary":"Multi-pronged media campaign to raise awareness about the disease and its impact on patients, family members and caregivers.Quoin’s QRX003 product is on track to obtain the first regulatory approval for Netherton Syndrome.Netherton Syndrome patients suffer from excess skin shedding as well as red, scaly skin that can cause painful itching and severe infections that can potentially lead to hospitalization, asthma, allergies and possibly skin cancer. They are also susceptible to water loss through the skin’s surface and are always at risk of dehydration. This chronic condition severely impacts every aspect of life for patients and their families, yet it remains inadequately understood and poorly addressed by current treatment options.The NETHERTON NOW website serves as a comprehensive resource hub, providing a platform for patients and families to share experiences and build connectio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quoin-pharmaceuticals-launches-netherton-now-123000008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GENE","LU1989764748.USD","LU0348723411.USD","LU1951198990.SGD","IE00B19Z9Z06.USD","LU1923623000.USD","LU2125909593.SGD","BK4581","LU1116320901.HKD","BK4588","IE00BMPRXR70.SGD","LU2023250504.SGD","LU1267930730.SGD","LU0320765059.SGD","LU0943347566.SGD","BK4543","BK4550","LU1923622291.USD","LU2087625088.SGD","IE00BMPRXN33.USD","BK4601","BK4097","BK4534","BK4503","LU0672654240.SGD","LU0889565833.HKD","LU1551013425.SGD","LU1153585028.USD","QNRX","LU2023250843.SGD","LU0109392836.USD","BK4121","ETH","LU2063271972.USD","LU1064131342.USD","LU1988902786.USD","LU2125909916.SGD","LU2125909247.SGD","LU2458330243.SGD","LU0265550359.USD","IE00B19Z9P08.USD","LU0265550946.USD","LU0316494557.USD","LU0354030438.USD","LU0689472784.USD","LU0820561818.USD","LU0708995401.HKD","LU0081259029.USD","LU2106854487.HKD"],"gpt_icon":1},{"id":"2508136072","title":"Insider Buyers At Quoin Pharmaceuticals Likely Disappointed With 13% Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2508136072","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508136072?lang=en_us&edition=fundamental","pubTime":"2025-02-02 22:49","pubTimestamp":1738507760,"startTime":"0","endTime":"0","summary":"The recent 13% drop in Quoin Pharmaceuticals, Ltd.'s  stock could come as a blow to insiders who purchased US$580.9k worth of stock at an average buy price of US$0.48 over the past 12 months. Insiders invest with the hopes of seeing their money grow in value over time. However, as a result of recent losses, their initial investment is now only worth US$404.8k, which is not what they expected.While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.Quoin Pharmaceuticals Insider Transactions Over The Last Year. Insiders At Quoin Pharmaceuticals Have Bought Stock Recently. The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-buyers-quoin-pharmaceuticals-likely-144920034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2506486033","title":"Quoin Pharmaceuticals: Buy Rating Affirmed Amidst Potential First-Mover Advantage in Netherton Syndrome Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2506486033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506486033?lang=en_us&edition=fundamental","pubTime":"2025-01-25 00:15","pubTimestamp":1737735312,"startTime":"0","endTime":"0","summary":"Analyst Naz Rahman from Maxim Group reiterated a Buy rating on Quoin Pharmaceuticals (QNRX – Research Report) and keeping the price target at $2.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/quoin-pharmaceuticals-buy-rating-affirmed-amidst-potential-first-mover-advantage-in-netherton-syndrome-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/quoin-pharmaceuticals-buy-rating-affirmed-amidst-potential-first-mover-advantage-in-netherton-syndrome-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX"],"gpt_icon":0},{"id":"2505026867","title":"Skinvisible Advances with Quoin Pharmaceuticals’ FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2505026867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505026867?lang=en_us&edition=fundamental","pubTime":"2025-01-24 04:52","pubTimestamp":1737665525,"startTime":"0","endTime":"0","summary":"Skinvisible ( ($SKVI) ) has issued an update. Skinvisible announced significant achievements in 2024 and 2025 through its licensee, Quoin Pharmaceu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/skinvisible-advances-with-quoin-pharmaceuticals-fda-clearance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/skinvisible-advances-with-quoin-pharmaceuticals-fda-clearance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2505134100","title":"Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2505134100","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505134100?lang=en_us&edition=fundamental","pubTime":"2025-01-23 21:30","pubTimestamp":1737639000,"startTime":"0","endTime":"0","summary":"Four Weeks After Discontinuation of Treatment with QRX003 Complete Reversal of Positive Clinical Improvements Across all Measured Endpoints ObservedData Supports QRX003 Mechanism of Action as a Compet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/23/3014276/0/en/Quoin-Pharmaceuticals-Announces-Further-Clinical-Evidence-of-QRX003-Effectiveness-in-Netherton-Syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2505095684","title":"Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2505095684","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505095684?lang=en_us&edition=fundamental","pubTime":"2025-01-23 18:30","pubTimestamp":1737628200,"startTime":"0","endTime":"0","summary":"LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. , , an innovative topical and transdermal pharmaceutical research and development company, with proprietary Invisicare drug delivery technology, today announces significant achievements in 2024 and 2025, through its licensee Quoin Pharmaceuticals' progress in Netherton Syndrome treatment.Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome. Netherton Syndrome is a hereditary disorder affecting the skin, hair, and immune system, currently lacking an approved treatment or cure. Quoin is responsible for obtaining all FDA and other regulatory body approvals necessary to market the products in the US and other countries. Upon the successful completion of FDA or EU approval, Skinvisible is entitled to receive a milestone payment of $5 million and ongoing royalties from s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/skinvisible-reports-licensee-success-netherton-103000058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SKVI","QNRX","BK4139","BK4183"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":50,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QNRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"QNRX","fiscalQuarterEnding":"2025/03","expectedEps":-3.85,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-6.5},{"market":"US","date":"2025-04-09","symbol":"QNRX","defaultRemindTime":1744205400000,"type":"split","dateTimestamp":1744171200000,"forFactor":35,"toFactor":1,"ratio":35},{"market":"US","date":"2025-03-13","symbol":"QNRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-11-07","symbol":"QNRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.47},{"market":"US","date":"2024-08-08","symbol":"QNRX","fiscalQuarterEnding":"2024/06","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QNRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QNRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1718251200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QNRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QNRX","date":"2025-06-12","current":-0.47797,"percent":0.475,"low":-17.346367,"twenty":-0.721599,"median":-0.459476,"eighty":-0.314428,"high":-0.000007,"avg":-0.798761,"sd":1.686373,"marketCap":4993529},"quantilePoints":[{"date":"2021-10-29","current":-17.346367,"twenty":-17.346367,"median":-17.346367,"eighty":-17.346367,"marketCap":97148313},{"date":"2021-11-05","current":-12.667021,"twenty":-16.958905,"median":-15.73691,"eighty":-14.60433,"marketCap":70941637},{"date":"2021-11-12","current":-8.658281,"twenty":-16.765174,"median":-12.667021,"eighty":-10.28264,"marketCap":48490695},{"date":"2021-11-19","current":-7.615115,"twenty":-14.708646,"median":-10.506176,"eighty":-8.241015,"marketCap":42648443},{"date":"2021-11-26","current":-3.943296,"twenty":-14.625193,"median":-8.598672,"eighty":-7.442247,"marketCap":37807719},{"date":"2021-12-03","current":-2.811666,"twenty":-13.054483,"median":-8.241015,"eighty":-3.931109,"marketCap":26957822},{"date":"2021-12-10","current":-3.055402,"twenty":-11.760956,"median":-7.592761,"eighty":-3.245167,"marketCap":29294723},{"date":"2021-12-17","current":-1.862838,"twenty":-10.890658,"median":-4.02164,"eighty":-3.025805,"marketCap":17860600},{"date":"2021-12-23","current":-1.549649,"twenty":-10.461469,"median":-3.943296,"eighty":-2.794256,"marketCap":16525228},{"date":"2021-12-31","current":-1.424425,"twenty":-9.308025,"median":-3.294786,"eighty":-1.787652,"marketCap":15189856},{"date":"2022-01-07","current":-1.627915,"twenty":-8.58675,"median":-3.203384,"eighty":-1.577825,"marketCap":17359836},{"date":"2022-01-14","current":-1.267895,"twenty":-8.485414,"median":-3.107631,"eighty":-1.488603,"marketCap":13520641},{"date":"2022-01-21","current":-1.0331,"twenty":-8.366195,"median":-2.876952,"eighty":-1.447905,"marketCap":11016819},{"date":"2022-01-28","current":-0.970488,"twenty":-8.163523,"median":-2.768142,"eighty":-1.377466,"marketCap":10349133},{"date":"2022-02-04","current":-1.111365,"twenty":-7.874416,"median":-1.976001,"eighty":-1.235023,"marketCap":11851426},{"date":"2022-02-11","current":-1.085306,"twenty":-7.597232,"median":-1.674874,"eighty":-1.127775,"marketCap":11573542},{"date":"2022-02-18","current":-1.061713,"twenty":-7.314087,"median":-1.573129,"eighty":-1.113525,"marketCap":11321943},{"date":"2022-02-25","current":-0.865099,"twenty":-6.348012,"median":-1.498777,"eighty":-1.105103,"marketCap":9225287},{"date":"2022-03-04","current":-0.904422,"twenty":-4.019899,"median":-1.479211,"eighty":-1.071673,"marketCap":9644618},{"date":"2022-03-11","current":-1.163952,"twenty":-3.999007,"median":-1.447905,"eighty":-1.061713,"marketCap":12412205},{"date":"2022-03-18","current":-1.163952,"twenty":-3.931109,"median":-1.416599,"eighty":-1.037796,"marketCap":12412205},{"date":"2022-03-25","current":-1.148223,"twenty":-3.765718,"median":-1.381379,"eighty":-1.057606,"marketCap":12244472},{"date":"2022-04-01","current":-1.053848,"twenty":-3.297397,"median":-1.299201,"eighty":-1.053848,"marketCap":11238077},{"date":"2022-04-08","current":-0.928015,"twenty":-3.283469,"median":-1.222936,"eighty":-1.035677,"marketCap":9896217},{"date":"2022-04-14","current":-0.476722,"twenty":-3.255613,"median":-1.205283,"eighty":-1.00962,"marketCap":10231682},{"date":"2022-04-22","current":-0.410293,"twenty":-3.203384,"median":-1.163952,"eighty":-0.975203,"marketCap":8805956},{"date":"2022-04-29","current":-0.313073,"twenty":-3.185975,"median":-1.153274,"eighty":-0.954835,"marketCap":6719363},{"date":"2022-05-06","current":-0.308697,"twenty":-3.15986,"median":-1.132494,"eighty":-0.920151,"marketCap":6625433},{"date":"2022-05-13","current":-0.243519,"twenty":-3.055402,"median":-1.120697,"eighty":-0.880828,"marketCap":5226544},{"date":"2022-05-20","current":-0.246137,"twenty":-2.907419,"median":-1.111365,"eighty":-0.857235,"marketCap":5282735},{"date":"2022-05-27","current":-0.275987,"twenty":-2.846486,"median":-1.107451,"eighty":-0.468907,"marketCap":5310410},{"date":"2022-06-03","current":-0.26812,"twenty":-2.81863,"median":-1.087972,"eighty":-0.44468,"marketCap":5159040},{"date":"2022-06-10","current":-0.203983,"twenty":-2.776847,"median":-1.085306,"eighty":-0.385285,"marketCap":3924940},{"date":"2022-06-17","current":-0.152291,"twenty":-2.489587,"median":-1.07351,"eighty":-0.319364,"marketCap":2930308},{"date":"2022-06-24","current":-0.155212,"twenty":-2.221478,"median":-1.061713,"eighty":-0.298542,"marketCap":2986515},{"date":"2022-07-01","current":-0.267305,"twenty":-1.953368,"median":-1.056579,"eighty":-0.277405,"marketCap":5143349},{"date":"2022-07-08","current":-0.231074,"twenty":-1.787652,"median":-1.053848,"eighty":-0.273302,"marketCap":4446216},{"date":"2022-07-15","current":-0.178755,"twenty":-1.674874,"median":-1.039542,"eighty":-0.267462,"marketCap":3439525},{"date":"2022-07-22","current":-0.183115,"twenty":-1.65609,"median":-1.030254,"eighty":-0.25072,"marketCap":3523416},{"date":"2022-07-29","current":-0.155517,"twenty":-1.615393,"median":-0.994864,"eighty":-0.244988,"marketCap":2992387},{"date":"2022-08-05","current":-1.0024,"twenty":-1.577825,"median":-0.983067,"eighty":-0.2438,"marketCap":19287705},{"date":"2022-08-12","current":-0.905761,"twenty":-1.530865,"median":-0.979135,"eighty":-0.244988,"marketCap":17428209},{"date":"2022-08-19","current":-1.261787,"twenty":-1.49956,"median":-0.983067,"eighty":-0.24634,"marketCap":22172308},{"date":"2022-08-26","current":-1.00506,"twenty":-1.494864,"median":-1.00373,"eighty":-0.247189,"marketCap":17661059},{"date":"2022-09-02","current":-0.83846,"twenty":-1.488603,"median":-0.983067,"eighty":-0.248209,"marketCap":14733547},{"date":"2022-09-09","current":-1.015985,"twenty":-1.47295,"median":-0.985942,"eighty":-0.249617,"marketCap":17853027},{"date":"2022-09-16","current":-0.999598,"twenty":-1.447905,"median":-1.000999,"eighty":-0.2541,"marketCap":17565075},{"date":"2022-09-23","current":-0.80537,"twenty":-1.447905,"median":-0.994135,"eighty":-0.255867,"marketCap":14152083},{"date":"2022-09-30","current":-0.61506,"twenty":-1.446166,"median":-0.983139,"eighty":-0.262906,"marketCap":10807926},{"date":"2022-10-07","current":-0.604028,"twenty":-1.436253,"median":-0.98189,"eighty":-0.267383,"marketCap":10614062},{"date":"2022-10-14","current":-0.471638,"twenty":-1.42286,"median":-0.968913,"eighty":-0.267782,"marketCap":8287692},{"date":"2022-10-21","current":-0.562656,"twenty":-1.413468,"median":-0.966397,"eighty":-0.2688,"marketCap":9887072},{"date":"2022-10-28","current":-0.529559,"twenty":-1.393119,"median":-0.950476,"eighty":-0.271699,"marketCap":9305479},{"date":"2022-11-04","current":-0.485429,"twenty":-1.358698,"median":-0.943659,"eighty":-0.272858,"marketCap":8530023},{"date":"2022-11-11","current":-0.479672,"twenty":-1.345188,"median":-0.923004,"eighty":-0.274906,"marketCap":9208547},{"date":"2022-11-18","current":-0.459476,"twenty":-1.332632,"median":-0.91334,"eighty":-0.276144,"marketCap":8820819},{"date":"2022-11-25","current":-0.462,"twenty":-1.299201,"median":-0.906739,"eighty":-0.276772,"marketCap":8869285},{"date":"2022-12-02","current":-0.441804,"twenty":-1.267895,"median":-0.903164,"eighty":-0.277827,"marketCap":8481557},{"date":"2022-12-09","current":-0.393836,"twenty":-1.261787,"median":-0.893083,"eighty":-0.277839,"marketCap":7560702},{"date":"2022-12-16","current":-0.386263,"twenty":-1.226868,"median":-0.869031,"eighty":-0.278907,"marketCap":7415304},{"date":"2022-12-23","current":-0.333246,"twenty":-1.219003,"median":-0.857235,"eighty":-0.28331,"marketCap":6397517},{"date":"2022-12-30","current":-0.358492,"twenty":-1.214288,"median":-0.83846,"eighty":-0.285895,"marketCap":6882177},{"date":"2023-01-06","current":-0.366066,"twenty":-1.203717,"median":-0.830267,"eighty":-0.294872,"marketCap":7027575},{"date":"2023-01-13","current":-0.419082,"twenty":-1.196726,"median":-0.751587,"eighty":-0.305389,"marketCap":8045362},{"date":"2023-01-20","current":-0.388787,"twenty":-1.192762,"median":-0.704699,"eighty":-0.310447,"marketCap":7463770},{"date":"2023-01-27","current":-0.393836,"twenty":-1.178108,"median":-0.684013,"eighty":-0.314277,"marketCap":7560702},{"date":"2023-02-03","current":-0.59078,"twenty":-1.163952,"median":-0.661949,"eighty":-0.317723,"marketCap":11341538},{"date":"2023-02-10","current":-0.421607,"twenty":-1.163758,"median":-0.631609,"eighty":-0.320717,"marketCap":8093828},{"date":"2023-02-17","current":-0.353443,"twenty":-1.161409,"median":-0.60749,"eighty":-0.323804,"marketCap":6785245},{"date":"2023-02-24","current":-0.118656,"twenty":-1.156304,"median":-0.591888,"eighty":-0.313675,"marketCap":2277903},{"date":"2023-03-03","current":-0.281484,"twenty":-1.14665,"median":-0.562656,"eighty":-0.29262,"marketCap":5403806},{"date":"2023-03-10","current":-0.522124,"twenty":-1.138785,"median":-0.550992,"eighty":-0.287367,"marketCap":4898302},{"date":"2023-03-17","current":-0.593625,"twenty":-1.130921,"median":-0.551624,"eighty":-0.29122,"marketCap":5569088},{"date":"2023-03-24","current":-0.65651,"twenty":-1.124629,"median":-0.575443,"eighty":-0.294825,"marketCap":6159049},{"date":"2023-03-31","current":-0.60057,"twenty":-1.123056,"median":-0.592995,"eighty":-0.300426,"marketCap":5634244},{"date":"2023-04-06","current":-0.603601,"twenty":-1.116764,"median":-0.60057,"eighty":-0.300426,"marketCap":5662676},{"date":"2023-04-14","current":-0.560679,"twenty":-1.116764,"median":-0.592742,"eighty":-0.308697,"marketCap":5260010},{"date":"2023-04-21","current":-0.580997,"twenty":-1.111365,"median":-0.593625,"eighty":-0.313073,"marketCap":5450622},{"date":"2023-04-28","current":-0.649313,"twenty":-1.111365,"median":-0.598171,"eighty":-0.316082,"marketCap":6091523},{"date":"2023-05-05","current":-0.60259,"twenty":-1.111365,"median":-0.60259,"eighty":-0.320185,"marketCap":5653199},{"date":"2023-05-12","current":-0.55198,"twenty":-1.103538,"median":-0.60158,"eighty":-0.321514,"marketCap":5686369},{"date":"2023-05-19","current":-0.55198,"twenty":-1.10065,"median":-0.595771,"eighty":-0.327238,"marketCap":5686369},{"date":"2023-05-26","current":-0.505982,"twenty":-1.088059,"median":-0.592742,"eighty":-0.333246,"marketCap":5212505},{"date":"2023-06-02","current":-0.499658,"twenty":-1.08792,"median":-0.589505,"eighty":-0.344867,"marketCap":5147361},{"date":"2023-06-09","current":-0.55704,"twenty":-1.087172,"median":-0.580997,"eighty":-0.350289,"marketCap":5738494},{"date":"2023-06-16","current":-0.620978,"twenty":-1.085644,"median":-0.584704,"eighty":-0.352938,"marketCap":6397166},{"date":"2023-06-23","current":-0.676176,"twenty":-1.085306,"median":-0.589505,"eighty":-0.356472,"marketCap":6965803},{"date":"2023-06-30","current":-0.593264,"twenty":-1.083207,"median":-0.591634,"eighty":-0.359502,"marketCap":6111663},{"date":"2023-07-07","current":-0.517481,"twenty":-1.079536,"median":-0.587708,"eighty":-0.361522,"marketCap":5330971},{"date":"2023-07-14","current":-0.54646,"twenty":-1.077168,"median":-0.582224,"eighty":-0.364046,"marketCap":5629506},{"date":"2023-07-21","current":-0.623853,"twenty":-1.07607,"median":-0.587708,"eighty":-0.366571,"marketCap":6426782},{"date":"2023-07-28","current":-0.721599,"twenty":-1.07607,"median":-0.591634,"eighty":-0.36859,"marketCap":7433744},{"date":"2023-08-04","current":-0.757094,"twenty":-1.073339,"median":-0.593264,"eighty":-0.36859,"marketCap":7374510},{"date":"2023-08-11","current":-0.62027,"twenty":-1.070607,"median":-0.595859,"eighty":-0.371115,"marketCap":6041768},{"date":"2023-08-18","current":-0.543243,"twenty":-1.069577,"median":-0.593625,"eighty":-0.376164,"marketCap":5291483},{"date":"2023-08-25","current":-0.538176,"twenty":-1.067876,"median":-0.592742,"eighty":-0.378689,"marketCap":5242122},{"date":"2023-09-01","current":-0.58277,"twenty":-1.065691,"median":-0.589505,"eighty":-0.378689,"marketCap":5676497},{"date":"2023-09-08","current":-0.590878,"twenty":-1.063086,"median":-0.590829,"eighty":-0.378689,"marketCap":5755475},{"date":"2023-09-15","current":-0.569594,"twenty":-1.061713,"median":-0.58823,"eighty":-0.378689,"marketCap":5548159},{"date":"2023-09-22","current":-0.506757,"twenty":-1.061713,"median":-0.585904,"eighty":-0.378689,"marketCap":4936085},{"date":"2023-09-29","current":-0.433865,"twenty":-1.060727,"median":-0.581611,"eighty":-0.380709,"marketCap":4226078},{"date":"2023-10-06","current":-0.427703,"twenty":-1.05818,"median":-0.578696,"eighty":-0.383738,"marketCap":4166055},{"date":"2023-10-13","current":-0.408953,"twenty":-1.055487,"median":-0.574156,"eighty":-0.383738,"marketCap":3983420},{"date":"2023-10-20","current":-0.41554,"twenty":-1.053848,"median":-0.568243,"eighty":-0.383738,"marketCap":4047589},{"date":"2023-10-27","current":-0.435811,"twenty":-1.053848,"median":-0.56578,"eighty":-0.383738,"marketCap":4245033},{"date":"2023-11-03","current":-0.435811,"twenty":-1.053848,"median":-0.56554,"eighty":-0.384243,"marketCap":4245033},{"date":"2023-11-10","current":-0.411508,"twenty":-1.050251,"median":-0.562656,"eighty":-0.384243,"marketCap":4008308},{"date":"2023-11-17","current":-0.498316,"twenty":-1.046658,"median":-0.560987,"eighty":-0.385884,"marketCap":4304279},{"date":"2023-11-24","current":-0.522671,"twenty":-1.041435,"median":-0.560318,"eighty":-0.386263,"marketCap":4514655},{"date":"2023-12-01","current":-0.568388,"twenty":-1.035221,"median":-0.558953,"eighty":-0.387777,"marketCap":4909543},{"date":"2023-12-08","current":-0.568034,"twenty":-1.0331,"median":-0.560318,"eighty":-0.388787,"marketCap":4906483},{"date":"2023-12-15","current":-0.484601,"twenty":-1.031392,"median":-0.558953,"eighty":-0.389637,"marketCap":4185812},{"date":"2023-12-22","current":-0.477732,"twenty":-1.021693,"median":-0.557743,"eighty":-0.390868,"marketCap":4126480},{"date":"2023-12-29","current":-0.588241,"twenty":-1.014712,"median":-0.55704,"eighty":-0.391312,"marketCap":5081023},{"date":"2024-01-05","current":-0.532603,"twenty":-1.010893,"median":-0.55589,"eighty":-0.391312,"marketCap":4600445},{"date":"2024-01-12","current":-0.526889,"twenty":-1.007253,"median":-0.553378,"eighty":-0.393331,"marketCap":4551084},{"date":"2024-01-19","current":-0.454873,"twenty":-1.0057,"median":-0.55198,"eighty":-0.393836,"marketCap":3929036},{"date":"2024-01-26","current":-0.427454,"twenty":-1.003464,"median":-0.551802,"eighty":-0.393836,"marketCap":3692202},{"date":"2024-02-02","current":-0.394309,"twenty":-1.000719,"median":-0.549335,"eighty":-0.39412,"marketCap":3405909},{"date":"2024-02-09","current":-0.38288,"twenty":-0.99632,"median":-0.548588,"eighty":-0.392826,"marketCap":3307187},{"date":"2024-02-16","current":-0.318876,"twenty":-0.989219,"median":-0.547495,"eighty":-0.388787,"marketCap":2754343},{"date":"2024-02-23","current":-0.301732,"twenty":-0.98485,"median":-0.546977,"eighty":-0.385127,"marketCap":2606260},{"date":"2024-03-01","current":-0.314316,"twenty":-0.983153,"median":-0.545642,"eighty":-0.383738,"marketCap":2714953},{"date":"2024-03-08","current":-0.135997,"twenty":-0.983067,"median":-0.543349,"eighty":-0.379908,"marketCap":1174693},{"date":"2024-03-15","current":-0.20704,"twenty":-0.982596,"median":-0.542611,"eighty":-0.378689,"marketCap":1798470},{"date":"2024-03-22","current":-0.381897,"twenty":-0.979215,"median":-0.541631,"eighty":-0.378689,"marketCap":3317373},{"date":"2024-03-28","current":-0.369167,"twenty":-0.97426,"median":-0.540481,"eighty":-0.37767,"marketCap":3206793},{"date":"2024-04-05","current":-0.364923,"twenty":-0.969858,"median":-0.539696,"eighty":-0.377263,"marketCap":3169934},{"date":"2024-04-12","current":-0.326734,"twenty":-0.967338,"median":-0.538176,"eighty":-0.369557,"marketCap":2838196},{"date":"2024-04-19","current":-0.305517,"twenty":-0.96715,"median":-0.536661,"eighty":-0.365152,"marketCap":2653898},{"date":"2024-04-26","current":-0.267328,"twenty":-0.964085,"median":-0.533552,"eighty":-0.358997,"marketCap":2322161},{"date":"2024-05-03","current":-0.309761,"twenty":-0.95419,"median":-0.531461,"eighty":-0.351423,"marketCap":2690758},{"date":"2024-05-10","current":-0.337342,"twenty":-0.951156,"median":-0.528981,"eighty":-0.340821,"marketCap":2930346},{"date":"2024-05-17","current":-0.367202,"twenty":-0.948223,"median":-0.527946,"eighty":-0.340821,"marketCap":3088456},{"date":"2024-05-24","current":-0.34075,"twenty":-0.943728,"median":-0.525421,"eighty":-0.340947,"marketCap":2865976},{"date":"2024-05-31","current":-0.331712,"twenty":-0.943659,"median":-0.525,"eighty":-0.340592,"marketCap":2789958},{"date":"2024-06-07","current":-0.346334,"twenty":-0.928015,"median":-0.523469,"eighty":-0.340703,"marketCap":2912940},{"date":"2024-06-14","current":-0.340703,"twenty":-0.926289,"median":-0.522398,"eighty":-0.340681,"marketCap":2865578},{"date":"2024-06-21","current":-0.295228,"twenty":-0.922433,"median":-0.519905,"eighty":-0.336816,"marketCap":2483103},{"date":"2024-06-28","current":-0.279187,"twenty":-0.920151,"median":-0.518004,"eighty":-0.336018,"marketCap":2348182},{"date":"2024-07-05","current":-0.274313,"twenty":-0.920151,"median":-0.512285,"eighty":-0.333064,"marketCap":2307188},{"date":"2024-07-12","current":-0.307579,"twenty":-0.914702,"median":-0.509745,"eighty":-0.331195,"marketCap":2586980},{"date":"2024-07-15","current":-0.310418,"twenty":-0.91334,"median":-0.508665,"eighty":-0.331019,"marketCap":2610860},{"date":"2024-08-02","current":-0.272562,"twenty":-0.913129,"median":-0.507585,"eighty":-0.329729,"marketCap":2292462},{"date":"2024-08-09","current":-0.248051,"twenty":-0.911177,"median":-0.505359,"eighty":-0.325114,"marketCap":2086300},{"date":"2024-08-16","current":-0.24035,"twenty":-0.906543,"median":-0.501744,"eighty":-0.319687,"marketCap":1989587},{"date":"2024-08-23","current":-0.293286,"twenty":-0.905493,"median":-0.497744,"eighty":-0.316091,"marketCap":2427781},{"date":"2024-08-30","current":-0.286555,"twenty":-0.903919,"median":-0.49203,"eighty":-0.313322,"marketCap":2372062},{"date":"2024-09-06","current":-0.383339,"twenty":-0.901905,"median":-0.490945,"eighty":-0.313073,"marketCap":3173230},{"date":"2024-09-13","current":-0.311556,"twenty":-0.894391,"median":-0.486542,"eighty":-0.313073,"marketCap":2579020},{"date":"2024-09-20","current":-0.276506,"twenty":-0.893083,"median":-0.485429,"eighty":-0.309761,"marketCap":2288880},{"date":"2024-09-27","current":-0.252418,"twenty":-0.880828,"median":-0.484661,"eighty":-0.307436,"marketCap":2089484},{"date":"2024-10-04","current":-0.23434,"twenty":-0.872964,"median":-0.484601,"eighty":-0.302929,"marketCap":1939837},{"date":"2024-10-11","current":-0.252827,"twenty":-0.865099,"median":-0.482434,"eighty":-0.301027,"marketCap":2092867},{"date":"2024-10-18","current":-0.317326,"twenty":-0.857235,"median":-0.47841,"eighty":-0.300426,"marketCap":2626780},{"date":"2024-10-25","current":-0.39995,"twenty":-0.857235,"median":-0.476537,"eighty":-0.300426,"marketCap":3310734},{"date":"2024-10-31","current":-0.494182,"twenty":-0.850943,"median":-0.478071,"eighty":-0.300907,"marketCap":4090778},{"date":"2024-11-08","current":-0.422626,"twenty":-0.840642,"median":-0.476351,"eighty":-0.301191,"marketCap":3498446},{"date":"2024-11-15","current":-0.352287,"twenty":-0.834605,"median":-0.468894,"eighty":-0.301334,"marketCap":3065275},{"date":"2024-11-22","current":-0.359821,"twenty":-0.830942,"median":-0.464302,"eighty":-0.301657,"marketCap":3130826},{"date":"2024-11-29","current":-0.348213,"twenty":-0.815329,"median":-0.462,"eighty":-0.30245,"marketCap":3029832},{"date":"2024-12-06","current":-0.435267,"twenty":-0.804556,"median":-0.461782,"eighty":-0.30359,"marketCap":3787290},{"date":"2024-12-13","current":-0.420758,"twenty":-0.775862,"median":-0.460599,"eighty":-0.304922,"marketCap":3661047},{"date":"2024-12-20","current":-0.375374,"twenty":-0.755346,"median":-0.458782,"eighty":-0.305517,"marketCap":3266158},{"date":"2024-12-27","current":-0.324419,"twenty":-0.754181,"median":-0.457684,"eighty":-0.304625,"marketCap":2822793},{"date":"2025-01-03","current":-0.389709,"twenty":-0.753938,"median":-0.457139,"eighty":-0.305517,"marketCap":3390886},{"date":"2025-01-10","current":-0.36162,"twenty":-0.752966,"median":-0.455912,"eighty":-0.305517,"marketCap":3146480},{"date":"2025-01-17","current":-0.342177,"twenty":-0.750208,"median":-0.452331,"eighty":-0.307436,"marketCap":2977309},{"date":"2025-01-24","current":-0.238758,"twenty":-0.74342,"median":-0.451013,"eighty":-0.307052,"marketCap":2077454},{"date":"2025-01-31","current":-0.167665,"twenty":-0.737124,"median":-0.449377,"eighty":-0.30269,"marketCap":1458864},{"date":"2025-02-07","current":-0.757086,"twenty":-0.737124,"median":-0.448569,"eighty":-0.301334,"marketCap":6587465},{"date":"2025-02-14","current":-0.783111,"twenty":-0.74342,"median":-0.449855,"eighty":-0.301657,"marketCap":6813909},{"date":"2025-02-21","current":-0.78737,"twenty":-0.751311,"median":-0.451168,"eighty":-0.30245,"marketCap":6850964},{"date":"2025-02-28","current":-0.840366,"twenty":-0.753452,"median":-0.452677,"eighty":-0.30359,"marketCap":7312086},{"date":"2025-03-07","current":-0.710242,"twenty":-0.753452,"median":-0.457022,"eighty":-0.304922,"marketCap":6179866},{"date":"2025-03-14","current":-0.697939,"twenty":-0.751311,"median":-0.45752,"eighty":-0.305517,"marketCap":6072819},{"date":"2025-03-21","current":-0.666099,"twenty":-0.746669,"median":-0.458782,"eighty":-0.306668,"marketCap":5969890},{"date":"2025-03-28","current":-0.654614,"twenty":-0.742758,"median":-0.460599,"eighty":-0.307522,"marketCap":5866961},{"date":"2025-04-04","current":-0.597422,"twenty":-0.741572,"median":-0.462322,"eighty":-0.30825,"marketCap":5354374},{"date":"2025-04-11","current":-0.360284,"twenty":-0.741572,"median":-0.462,"eighty":-0.309143,"marketCap":3229031},{"date":"2025-04-17","current":-0.393753,"twenty":-0.739272,"median":-0.460599,"eighty":-0.309568,"marketCap":3528996},{"date":"2025-04-25","current":-0.435271,"twenty":-0.735618,"median":-0.459466,"eighty":-0.310024,"marketCap":3901103},{"date":"2025-05-02","current":-0.433456,"twenty":-0.734421,"median":-0.458108,"eighty":-0.310681,"marketCap":3884836},{"date":"2025-05-09","current":-0.410992,"twenty":-0.733427,"median":-0.457352,"eighty":-0.311268,"marketCap":3683507},{"date":"2025-05-16","current":-0.433495,"twenty":-0.733238,"median":-0.456951,"eighty":-0.312163,"marketCap":4528878},{"date":"2025-05-23","current":-0.476844,"twenty":-0.73159,"median":-0.457022,"eighty":-0.313182,"marketCap":4981766},{"date":"2025-05-30","current":-0.510623,"twenty":-0.72928,"median":-0.457352,"eighty":-0.313539,"marketCap":5334665},{"date":"2025-06-06","current":-0.492889,"twenty":-0.726897,"median":-0.458108,"eighty":-0.314338,"marketCap":5149393},{"date":"2025-06-12","current":-0.47797,"twenty":-0.721599,"median":-0.459476,"eighty":-0.314428,"marketCap":4993529}],"updateTime":1749880757129}}}